Fox Run Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$269K Buy
2025
Q2
Sell
2025
Q1
$276K Sell
2024
Q4
$448K Buy
2024
Q3
Sell
2024
Q2
$231K Buy
2024
Q1
Sell
2023
Q4
$177K Buy
2023
Q3
Sell
2023
Q2
$281K Buy
2018
Q1
Sell
2017
Q4
$368K Buy
2017
Q3
Sell
2017
Q2
$246K Buy
2016
Q1
Sell
2015
Q4
$324K Buy